CHARACTERIZATION OF THE US FOOD AND DRUG ADMINISTRATION POST--MARKETING COMMITMENTS AND REQUIREMENTS FOR PREGNANCY AND LACTATION

被引：0
|
作者：
Avachat, C. [1 ]
Younis, I. [2 ]
Birnbaum, A. [1 ]
机构：
[1] Univ Minnesota, Minneapolis, MN USA
[2] Gilead Sci, Herndon, VA USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2023年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI-083
引用
收藏
页码：S40 / S40
页数：1
相关论文
共 50 条
  • [1] Characterization of the US Food and Drug Administration Post-Marketing Commitments and Requirements for Pregnancy and Lactation
    Avachat, Charul
    Younis, Islam R.
    Birnbaum, Angela K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 114 (06) : 1238 - 1242
  • [2] US FOOD AND DRUG ADMINISTRATION (FDA) POSTMARKETING REQUIREMENTS AND COMMITMENTS RELATED TO DRUG DISPOSITION IN LACTATION AND PREGNANCY
    Ridge, S.
    Ramamoorthy, A.
    Guinn, D.
    Zineh, I.
    Fletcher, E. Pfuma
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S77 - S77
  • [3] TRENDS IN POST-MARKETING COMMITMENTS RELATED TO PREGNANCY AND LACTATION
    Albano, J. D.
    Roberts, S. S.
    Benter, U.
    Whitehouse, J.
    VALUE IN HEALTH, 2012, 15 (07) : A545 - A545
  • [4] The 2015 US Food and Drug Administration Pregnancy and Lactation Labeling Rule
    Brucker, Mary C.
    King, Tekoa L.
    JOURNAL OF MIDWIFERY & WOMENS HEALTH, 2017, 62 (03) : 308 - 316
  • [5] Impact of the FDAAA on Post-Marketing Commitments Related to Pregnancy and Lactation
    Albano, Jessica D.
    Roberts, Susan Sinclair
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 141 - 142
  • [6] US Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009-2018
    Skydel, Joshua J.
    Zhang, Audrey D.
    Dhruva, Sanket S.
    Ross, Joseph S.
    Wallach, Joshua D.
    CLINICAL TRIALS, 2021, 18 (04) : 488 - 499
  • [7] CHANGES IN FDA POST-MARKETING COMMITMENTS TO SUPPORT THE PREGNANCY AND LACTATION LABELING RULE
    Covington, D.
    Buus, R.
    Mabe, B.
    VALUE IN HEALTH, 2018, 21 : S147 - S147
  • [8] The new US Food and Drug Administration pregnancy and lactation labeling rules: Their impact on clinical practice
    Danesh, Melissa J.
    Murase, Jenny E.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 73 (02) : 310 - 311
  • [9] Analysis of Postapproval Clinical Trials of Therapeutics Approved by the US Food and Drug Administration Without Clinical Postmarketing Requirements or Commitments
    Skydel, Joshua J.
    Luxkaranayagam, Anita T.
    Dhruva, Sanket S.
    Ross, Joseph S.
    Wallach, Joshua D.
    JAMA NETWORK OPEN, 2019, 2 (05)
  • [10] Recent Trends in US FDA Post-Marketing Commitments (PMCs) for Pregnancy Safety Studies
    Buus, R.
    Covington, D.
    Veley, K.
    Robinson, M.
    Churchill, P.
    BIRTH DEFECTS RESEARCH, 2020, 112 (11): : 865 - 865
12345